Gentamicin Eye Drops Suppliers & Bulk Manufacturers

Available Forms: Drops

Available Strengths: 0.3% solution

Reference Brands: Garamycin (USA), Genoptic (USA) , Gentak

Category: Opthalmology

Gentamicin Eye Drops (0.3%) are an aminoglycoside antibiotic used in ophthalmology to treat bacterial eye infections including conjunctivitis, keratitis, and blepharitis. Marketed under brands like Genoptic® and Garamycin® in the USA, EU, and UK, Gentamicin is a reliable choice for effective ocular infection management. Gentamicin Eye Drops is available in Drops and strengths such as 0.3% solution. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Gentamicin Eye Drops is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Gentamicin Eye Drops can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Gentamicin sulfate ophthalmic solution is a widely used antibiotic formulation indicated for the treatment of superficial bacterial infections of the eye and surrounding structures. It is commonly prescribed for conditions such as bacterial conjunctivitis, blepharitis, and other infections affecting the eyelids and ocular surface. With a typical concentration of 0.3%, it provides effective coverage against a range of susceptible Gram-positive and Gram-negative bacteria.

The medication works by inhibiting bacterial protein synthesis, ultimately leading to the death of the infecting organisms. This bactericidal action helps reduce symptoms such as redness, swelling, irritation, and discharge from the eyes, promoting faster recovery.

Gentamicin eye drops are usually administered as 1–2 drops into the affected eye(s) every 4 hours, although the dosage may vary depending on the severity of the infection and clinical response. Due to its proven efficacy and reliability, it remains a commonly prescribed treatment in ophthalmic care. As with all antibiotics, it should be used under medical supervision to ensure appropriate use and to minimize the risk of resistance.